Clinical Trial Update: Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating Shenfu Injection for reducing myocardial injury in myocardial infarction patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Shenfu Injection

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Myocardial Infarction | Phase 4 | Status: UNKNOWN